Minimed
This article was originally published in The Gray Sheet
Executive Summary
Launches Model 407C infusion pump for general medication use following 510(k) clearance June 23. Similar to the firm's insulin infusion pumps and designed to deliver medications suitable for subcutaneous administration, the 407C represents diversification of the firm's technology to include disease states other than diabetes. MiniMed expects the device to be first used in connection with its alliance with United Therapeutics for the treatment of pulmonary hypertension